Triclabendazole progress report, 2005-2009: an advancement of learning? (Q37444251)

20 August 2017

1 reference

title

Triclabendazole progress report, 2005-2009: an advancement of learning? (English)

1 reference

20 August 2017

1 reference

I Fairweather

1

1 reference

20 August 2017

15 April 2009

1 reference

20 August 2017

Journal of Helminthology

1 reference

20 August 2017

83

1 reference

20 August 2017

139-150

1 reference

20 August 2017

2

1 reference

Control of human fascioliasis by selective chemotherapy: design, cost and effect of the first public health, school-based intervention implemented in endemic areas of the Nile Delta, Egypt

20 August 2017

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

Treatment of human fascioliasis with triclabendazole: good news

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

Resistance-induced changes in triclabendazole transport in Fasciola hepatica: ivermectin reversal effect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

New medicines from nature's armamentarium

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

Drug transport mechanisms in helminth parasites: passive diffusion of benzimidazole anthelmintics

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

Triclabendazole biotransformation and comparative diffusion of the parent drug and its oxidized metabolites into Fasciola hepatica

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

Resistance of Fasciola hepatica against triclabendazole in cattle and sheep in The netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

Effects of the multidrug-resistance-reversing agents verapamil and CL 347,099 on the efficacy of ivermectin or moxidectin against unselected and drug-selected strains of Haemonchus contortus in jirds (Meriones unguiculatus).

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

Pharmacokinetic disposition of triclabendazole in cattle and sheep; discrimination of the order and the rate of the absorption process of its active metabolite triclabendazole sulfoxide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

Schistosomiasis and soil-transmitted helminthiasis: common drugs for treatment and control

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

Artemether and tribendimidine lack activity in experimental treatment of Paragonimus westermani in the dog.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

A possible model of benzimidazole binding to beta-tubulin disclosed by invoking an inter-domain movement

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

The comparative metabolism of triclabendazole sulphoxide by triclabendazole-susceptible and triclabendazole-resistant Fasciola hepatica.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

Triclabendazole-resistant Fasciola hepatica: beta-tubulin and response to in vitro treatment with triclabendazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

Triclabendazole: new skills to unravel an old(ish) enigma

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

Effect of Fascioliasis on the pharmacokinetic parameters of triclabendazole in human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

Effect of the metabolic inhibitor, methimazole on the drug susceptibility of a triclabendazole-resistant isolate of Fasciola hepatica

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

Paramphistomicidal efficacy of an experimental compound in sheep

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

P-glycoprotein in helminths: function and perspectives for anthelmintic treatment and reversal of resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

Clonorchicidal properties of the synthetic trioxolane OZ78.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

Evaluation of the in vivo activity of tribendimidine against Schistosoma mansoni, Fasciola hepatica, Clonorchis sinensis, and Opisthorchis viverrini

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

Activity of artemether and OZ78 against triclabendazole-resistant Fasciola hepatica

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

Artesunate and artemether are effective fasciolicides in the rat model and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

The synthetic peroxide OZ78 is effective against Echinostoma caproni and Fasciola hepatica

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

Trematocidal activity of praziquantel and artemisinin derivatives: in vitro and in vivo investigations with adult Echinostoma caproni

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

Effect of artesunate and artemether against Clonorchis sinensis and Opisthorchis viverrini in rodent models

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

Triclabendazole for the treatment of fascioliasis and paragonimiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

Artemisinins and synthetic trioxolanes in the treatment of helminth infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

Food-borne trematodiasis: current chemotherapy and advances with artemisinins and synthetic trioxolanes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

Fasciola hepatica: Surface tegumental responses to in vitro and in vivo treatment with the experimental fasciolicide OZ78.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

Fasciola hepatica: tegumental alterations in adult flukes following in vitro and in vivo administration of artesunate and artemether

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

Natural products as antiparasitic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

Propolis extracts are effective against Trypanosoma cruzi and have an impact on its interaction with host cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

An in vitro effect of propolis on adult worms of Fasciola gigantica.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

Fasciola hepatica: Histology of the testis in egg-producing adults of several laboratory-maintained isolates of flukes grown to maturity in cattle and sheep and in flukes from naturally infected hosts

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

Prospects for plant anthelmintics in tropical veterinary medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

Relative activity of triclabendazole metabolites against the liver fluke, Fasciola hepatica

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

Avermectins and milbemycins against Fasciola hepatica: in vivo drug efficacy and in vitro receptor binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

Tegumental surface changes in juvenile Fasciola hepatica in response to treatment in vivo with triclabendazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

Phenotyping and genotyping of Haemonchus contortus isolates reveals a new putative candidate mutation for benzimidazole resistance in nematodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

Managing parasiticide resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

The effect of albendazole and triclabendazole on colchicine binding in the liver fluke Fasciola hepatica

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

Plasma achiral and chiral pharmacokinetic behaviour of intravenous oxfendazole co-administered with piperonyl butoxide in sheep

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

Fasciola hepatica expresses multiple alpha- and beta-tubulin isotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

Fasciolicides: efficacy, actions, resistance and its management

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

Drug resistance in veterinary helminths

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

Activity of oxyclozanide, nitroxynil, clorsulon and albendazole against adult triclabendazole-resistant Fasciola hepatica

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

Comparison of two single-day regimens of triclabendazole for the treatment of human pulmonary paragonimiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

Antimalarial chemotherapeutic peroxides: artemisinin, yingzhaosu A and related compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

Intestinal elimination of albendazole sulfoxide: pharmacokinetic effects of inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

Lack of reversion in triclabendazole-resistant Fasciola hepatica

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

Fasciola hepatica: ultrastructural effects of a combination of triclabendazole and clorsulon against mature fluke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

Morphological response of triclabendazole-susceptible and triclabendazole-resistant isolates of Fasciola hepatica to treatment in vitro with nitroxynil (Trodax).

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

Worm control and anthelmintic resistance: adventures with a model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

Ultrastructural changes induced in the tegument and gut of Fasciola hepatica following in vivo and in vitro drug treatment with nitroxynil (Trodax).

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

Use of triclabendazole for treatment of patients co-infected by Fasciola spp. and S. mansoni in Behera Governorate, Egypt

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

Antimicrobial susceptibility of Enterococcus strains isolated from poultry faeces.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

Surface and internal tegumental changes in juvenile Fasciola hepatica following treatment in vivo with the experimental fasciolicide, compound alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

Immature triclabendazole-resistant Fasciola hepatica: tegumental responses to in vitro treatment with the sulphoxide metabolite of the experimental fasciolicide compound alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

Inhibition of cytochrome P450 activity enhances the systemic availability of triclabendazole metabolites in sheep

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

Identification of an antimalarial synthetic trioxolane drug development candidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

Physiological and morphological effects of genistein against the liver fluke, Fasciola hepatica

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

In vitro anthelmintic effects of cysteine proteinases from plants against intestinal helminths of rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

In vitro and in vivo treatments of echinococcus protoscoleces and metacestodes with artemisinin and artemisinin derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

Artemether, artesunate, praziquantel and tribendimidine administered singly at different dosages against Clonorchis sinensis: a comparative in vivo study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

Adult triclabendazole-resistant Fasciola hepatica: surface and subsurface tegumental responses to in vitro treatment with the sulphoxide metabolite of the experimental fasciolicide compound alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

Fascioliasis and other plant-borne trematode zoonoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

Development of antischistosomal drugs in China, with particular consideration to praziquantel and the artemisinins

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

An Over Four Millennium Story Behind Qinghaosu (Artemisinin)-A Fantastic Antimalarial Drug from a Traditional Chinese Herb

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

ABC transporter modulation: a strategy to enhance the activity of macrocyclic lactone anthelmintics

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

Fasciolicidal efficacy of Albizia anthelmintica and Balanites aegyptiaca compared with albendazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

Involvement of P-glycoprotein on ivermectin kinetic behaviour in sheep: itraconazole-mediated changes on gastrointestinal disposition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

Plant active components - a resource for antiparasitic agents?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

Enhanced absorption of pour-on ivermectin formulation in rats by co-administration of the multidrug-resistant-reversing agent verapamil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

Role of ABC transporters in veterinary drug research and parasite resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

Altered drug influx/efflux and enhanced metabolic activity in triclabendazole-resistant liver flukes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

Methods to sustain drug efficacy in helminth control programmes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

Inhibitory effect of Egyptian propolis on Fasciola gigantica eggs with reference to its effect on Clostridium oedematiens and correlation to chemical composition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

7 January 2021

Combined use of ivermectin and triclabendazole in sheep: in vitro and in vivo characterisation of their pharmacological interaction

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

7 January 2021

Adult triclabendazole-resistant Fasciola hepatica: morphological changes in the tegument and gut following in vivo treatment with artemether in the rat model

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

7 January 2021

A scanning electron microscope study on the route of entry of triclabendazole into the liver fluke, Fasciola hepatica

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

7 January 2021

The kinetics of triclabendazole disposition in sheep

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

7 January 2021

Methimazole increases the plasma concentrations of the albendazole metabolites of netobimin in sheep

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

7 January 2021

Fasciola hepatica: morphological effects of a combination of triclabendazole and clorsulon against mature fluke

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

7 January 2021

Fitness of benzimidazole-resistant and -susceptible worms of Teladorsagia circumcincta, a nematode parasite of small ruminants

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

7 January 2021

Schistosoma japonicum: In vitro effects of artemether combined with haemin depend on cultivation media and appraisal of artemether products appearing in the media

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

7 January 2021

Modulation of the P-glycoprotein-mediated intestinal secretion of ivermectin: in vitro and in vivo assessments.

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

7 January 2021

Interaction between Fenbendazole and Piperonyl Butoxide: Pharmacokinetic and Pharmacodynamic Implications

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

7 January 2021

Activity of closantel against adult triclabendazole-resistant Fasciola hepatica

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

7 January 2021

Genistein from Flemingia vestita (Fabaceae) enhances NO and its mediator (cGMP) production in a cestode parasite, Raillietina echinobothrida

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

7 January 2021

Methimazole-mediated enhancement of albendazole oral bioavailability and anthelmintic effects against parenteral stages of Trichinella spiralis in mice: the influence of the dose-regime

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

7 January 2021

Effect of selection pressure for thiabendazole resistance on fitness of Haemonchus contortus in sheep

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

7 January 2021

An evaluation of the efficacy of compound alpha and triclabendazole against two isolates of Fasciola hepatica

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

7 January 2021

Resistance of Fasciola hepatica to triclabendazole and albendazole in sheep in Spain

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

7 January 2021

Pharmacokinetic behavior in sheep and cattle of 5-chloro-2-(methylthio)-6-(1-naphthyloxy)-1H-benzimidazole, a new fasciolicide agent

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

7 January 2021

High-performance liquid chromatographic assay for a new fasciolicide agent, alphaBIOF10, in biological fluids

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

7 January 2021

Assessment of the main metabolism pathways for the flukicidal compound triclabendazole in sheep

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

7 January 2021

Stage-specific differences in fecundity over the life-cycle of two characterized isolates of the liver fluke, Fasciola hepatica

1 reference

https://api.crossref.org/works/10.1017%2FS0022149X09321173

7 January 2021

10.1017/S0022149X09321173

Identifiers

DOI

1 reference

release_hdpj7qnd4zdszlmrhwioqgh27q

20 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hdpj7qnd4zdszlmrhwioqgh27q

24 November 2022

mapped directly with Wikidata item

PubMed ID

19366485

1 reference

PubMed ID

19366485